Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Alvespimycin
Sponsor: Bristol-Myers Squibb